A regulatory first and what it means Japan’s regulators have cleared two novel cell‑based therapies, one aimed at treating Parkinson’s disease and another for severe heart failure. These approvals are notable because the Parkinson’s therapy is built on induce…
Japans regulators have cleared two novel cellbased therapies, one aimed at treating Parkinsons disease and another for severe heart failure. These approvals are notable because the Parkinsons therapy… [+1812 chars]
